We're proud to present Xinvento. Our purpose is to develop the future treatment of congenital hyperinsulinism. We've launched our website https://t.co/FIj35BI1Pu, so check it out and learn more about the disease, the team, and our mission. #biotech#pharma#RareDisease#impact
Did you know that Congenital Hyperinsulinism is the most persistent cause of Hypoglycemia in babies and children? Learn more about HI by visiting: https://t.co/0xmNR3RzRr
#Hyperinsulinism#raredisease#rarediseaseresearch
We’re so proud that our founder, Claudine van de Sande, is part of the The Termeer Foundation Legacy Program! Congratulations to the other Termeer Fellows! @The_Termeer_Fdn #womeninbiotech https://t.co/mtNGPACCpD
It was great to be part of the Henri Termeer and Massachusetts - leadership in life sciences and innovation session yesterday at Innovation for Health
@I4Hevent event, sponsored by @HealthHolland. Thank you for the invite. #health